Clinical Trials in Philadelphia

Showing 15261-15280 of 20,904 trials

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

NCT01021553

To determine if an on demand dosing of 50 mg or 150 mg of GSK557296 demonstrates superior efficacy with respect to duration of intra vaginal ejaculatory latency time (IELT) during an 8 week study period compared to placebo in men with primary premature ejaculation. An assessment of the safety and tolerability of all doses of GSK557296 will be performed as well as an assessment for change in the Index of Premature Ejaculation (IPE) from baseline and at the end of the 8 weeks of treatment. During the active treatment period study participants will be limited to a maximum of 40 doses of GSK557296, or placebo, spilt as 20 doses for both 4 week intervals.

Premature Ejaculation

GlaxoSmithKline77 participantsStarted Dec 2009

San Diego, California, United States • San Jose, California, United States • Fort Wayne, Indiana, United States +5 more locations

COMPLETED< 1 mile

Safety of Riluzole in Patients With Acute Spinal Cord Injury

NCT00876889

The purpose of the study is to find out if the use of the drug Riluzole is both safe and improves outcome in patients with acute traumatic spinal cord injury (SCI).

Spinal Cord Injury

The Methodist Hospital Research Institute36 participantsStarted Apr 2010

Miami, Florida, United States • Louisville, Kentucky, United States • Baltimore, Maryland, United States +5 more locations

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

Safety of Riluzole in Patients With Acute Spinal Cord Injury

Find Trials by Condition in Philadelphia

Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery

Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Green Tea and Ultraviolet Light-induced Skin Damage

GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment

Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea

Healthy.io Method Comparison & User Performance Study

GSK2251052 in Complicated Urinary Tract Infection

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin